tiprankstipranks
Trending News
More News >
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA
Germany Market

Heidelberg Pharma AG (HPHA) Financial Statements

Compare
6 Followers

Heidelberg Pharma AG Financial Overview

Heidelberg Pharma AG's market cap is currently €149.71M. The company's EPS TTM is €-0.143; its P/E ratio is -5.70; Heidelberg Pharma AG is scheduled to report earnings on July 10, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 6.85M€ 9.86M€ 18.51M€ 1.75M€ 8.49M
Gross Profit€ 4.20M€ 6.61M€ 13.83M€ -2.96M€ 2.89M
Operating Income€ -24.56M€ -21.21M€ -18.33M€ -25.63M€ -18.56M
EBITDA€ -18.37M€ -18.71M€ -16.19M€ -24.83M€ -17.55M
Net Income€ -19.38M€ -20.35M€ -19.70M€ -26.63M€ -18.37M
Balance Sheet
Cash & Short-Term Investments€ 29.42M€ 43.44M€ 81.33M€ 6.14M€ 4.98M
Total Assets€ 60.72M€ 70.35M€ 100.58M€ 21.73M€ 19.61M
Total Debt€ 21.97M€ 5.83M€ 15.98M€ 10.63M€ 202.68K
Net Debt€ -7.45M€ -37.61M€ -65.35M€ 4.49M€ -4.78M
Total Liabilities€ 29.85M€ 21.01M€ 33.94M€ 15.03M€ 6.73M
Stockholders' Equity€ 30.87M€ 49.34M€ 66.64M€ 6.70M€ 12.88M
Cash Flow
Free Cash Flow€ -30.04M€ -34.63M€ -9.48M€ -28.00M€ -19.33M
Operating Cash Flow€ -29.59M€ -33.67M€ -8.86M€ -26.61M€ -17.89M
Investing Cash Flow€ -449.13K€ 5.85M€ -597.57K€ -1.40M€ -1.29M
Financing Cash Flow€ 16.08M€ -10.05M€ 84.00M€ 29.17M€ 14.29M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

Heidelberg Pharma AG Debt to Assets

Heidelberg Pharma AG Cash Flow

Heidelberg Pharma AG Forecast EPS vs Actual EPS